Medication Adherence, Comorbidities, and Health Risk Impacts on Workforce Absence and Job Performance

US Preventive Medicine Inc., Jacksonville, FL, USA.
Journal of occupational and environmental medicine / American College of Occupational and Environmental Medicine (Impact Factor: 1.63). 06/2011; 53(6):595-604. DOI: 10.1097/JOM.0b013e318223470b
Source: PubMed

ABSTRACT To understand impacts of medication adherence, comorbidities, and health risks on workforce absence and job performance.
Retrospective observational study using employees' medical/pharmacy claims and self-reported health risk appraisals.
Statin medication adherence in individuals with Coronary Artery Disease was significant predictor (P < 0.05) of decreasing absenteeism. Insulin, oral hypoglycemic, or metformin medication adherence in type 2 diabetics was significant (P < 0.05) predictor of decreasing job performance. Number of comorbidities was found as significant (P < 0.5) predictor of absenteeism in five of nine subsamples. Significant links (P < 0.05) between high health risks and lower job performance were found across all nine subsamples.
Results suggest integrated health and productivity management strategies should include an emphasis on primary and secondary prevention to reduce health risks in addition to tertiary prevention efforts of disease management and medication management.

Download full-text


Available from: Ronald Loeppke, Oct 27, 2014
1 Follower
39 Reads
  • Source
    • "Recent studies have quantifi ed the resource implications associated with severe hypoglycaemia episodes (SHE) and non-severe hypoglycaemia episodes (NSHE) [1] [2] [3] [4] [5]. "
    ISPOR, Dublin, Ireland; 11/2013
  • [Show abstract] [Hide abstract]
    ABSTRACT: To estimate the impact of medication adherence on absenteeism and short-term disability among employees with chronic disease. Cross-sectional analysis of administrative health care claims, absenteeism, and short-term disability data using multivariate regression and instrumental variable models for five cohorts of employees: diabetes, hypertension, congestive heart failure, dyslipidemia, and asthma/chronic obstructive pulmonary disease. Adherence was defined as possessing medication on at least 80% of days during follow-up. Adherent employees with diabetes, hypertension, dyslipidemia, and asthma/chronic obstructive pulmonary disease realized between 1.7 and 7.1 fewer days absent from work and between 1.1 and 5.0 fewer days on short-term disability. Absenteeism and short-term disability days by adherent employees with congestive heart failure were not significantly different from nonadherent employees with the condition in most specifications. Appropriate management of chronic conditions can help employers minimize losses due to missed work.
    Journal of occupational and environmental medicine / American College of Occupational and Environmental Medicine 07/2012; 54(7):792-805. DOI:10.1097/JOM.0b013e31825463e9 · 1.63 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Abstract This study evaluated the relationships between compliance with oral hypoglycemic agents and health care/short-term disability costs in a large manufacturing company. The retrospective analysis used an observational cohort drawn from active employees of Ford Motor Company. The study population consisted of 4978 individuals who were continuously eligible for 3 years (between 2001-2007) and who received a prescription for an oral hypoglycemic agent during that time. Medical, pharmacy, and short-term disability claims data were obtained from the University of Michigan Health Management Research Center data warehouse. Pharmacy claims/refill data were used to calculate the proportion of days covered (PDC); an individual was classified as compliant if his/her PDC was ≥80%. Model covariates included age, sex, work type, and Charlson comorbidity scores. The impact of compliance on disability and health care costs was measured by comparing the costs of the compliant with those of the noncompliant during a 1-year follow-up. Among these employees, compliant patients had lower medical, higher pharmacy, and lower short-term disability costs than did the noncompliant. After adjusting for demographics and comorbidity, noncompliance was associated with statistically higher short-term disability costs ($1840 vs. $1161, P<0.0001), longer short-term disability duration, and an increase in short-term disability incidence (21.5% of the noncompliant had a claim compared to 16.0% of the compliant, P<0.0001). These results suggest that medication compliance may be important in curtailing the rise of health care/disability costs in the workplace. Employers concerned with the total costs associated with diabetes should not overlook the impact of compliance on short-term disability. (Population Health Management 2013;xx:xxx-xxx).
    Population Health Management 07/2013; 17(1). DOI:10.1089/pop.2013.0009 · 1.51 Impact Factor
Show more